Cited by 238Neuroendocrine Tumor Research AdvancesGenetic factors in colorectal cancerNeuroblastoma Research and Treatments

An Organoid Biobank of Neuroendocrine Neoplasms Enables Genotype-Phenotype Mapping

Open access
Kawasaki, Kenta, Toshimitsu, Kohta, Matano, Mami, Fujita, Masashi, Fujii, Masayuki, Togasaki, Kazuhiro, Ebisudani, Toshiki, Shimokawa, Mariko +28 more·2020·Cell

Abstract

Gastroenteropancreatic (GEP) neuroendocrine neoplasm (NEN) that consists of neuroendocrine tumor and neuroendocrine carcinoma (NEC) is a lethal but under-investigated disease owing to its rarity. To fill the scarcity of clinically relevant models of GEP-NEN, we here established 25 lines of NEN organoids and performed their comprehensive molecular characterization. GEP-NEN organoids recapitulated pathohistological and functional phenotypes of the original tumors. Whole-genome sequencing revealed frequent genetic alterations in TP53 and RB1 in GEP-NECs, and characteristic chromosome-wide loss of heterozygosity in GEP-NENs. Transcriptome analysis identified molecular subtypes that are distinguished by the expression of distinct transcription factors. GEP-NEN organoids gained independence from the stem cell niche irrespective of genetic mutations. Compound knockout of TP53 and RB1, together with overexpression of key transcription factors, conferred on the normal colonic epithelium phenotypes that are compatible with GEP-NEN biology. Altogether, our study not only provides genetic understanding of GEP-NEN, but also connects its genetics and biological phenotypes.

Integrity signals

Registry

Crossref · 10.1016/j.cell.2020.10.023

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Hubert and colleagues showed that glioblastoma multiforme cells cultured as tumorspheres displayed a solid growth pattern, whereas organoids were more diffusive, similar to the tumor of origin.

    “They showed that while cells from tumorspheres displayed a solid growth pattern, organoids were more diffusive, similar to the tumor of origin172.”

    From Organoids (2022) · cites this paper as [172]

  • Tumoroid biobanks can be used as in vitro models of tumorigenesis and offer a significant advantage over conventional 2D cell culture technology.

    “These tumoroid biobanks can then be used as in vitro models of tumorigenesis and offer a significant advantage over conventional 2D cell culture technology5,6.”

Cites

Flagged first, then by citations

1 of the 71 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Kawasaki, K., Toshimitsu, K., Matano, M., Fujita, M., Fujii, M., Togasaki, K., Ebisudani, T., Shimokawa, M., Takano, A., Takahashi, S., Ohta, Y., Nanki, K., Igarashi, R., Ishimaru, K., Ishida, H., Sukawa, Y., Sugimoto, S., Saito, Y., Maejima, K., Sasagawa, S., Lee, H., Kim, H.-G., Ha, K., Hamamoto, J., Fukunaga, K., Maekawa, A., Tanabe, M., Ishihara, S., Hamamoto, Y., Yasuda, H., Sekine, S., Kudo, A., Kitagawa, Y., Kanai, T., Nakagawa, H., & Sato, T.
Affiliations
  • Keio University (JP)
  • RIKEN Center for Integrative Medical Sciences (JP)
  • Seoul National University (KR)
  • Tokyo Medical and Dental University (JP)
  • The University of Tokyo (JP)
  • National Cancer Center Hospital (JP)
Corresponding author
Sato, Toshiro
Venue
Cell
Publisher
Elsevier BV
Published
2020-11
Volume
183
Issue
5
Pages
1420-1435.e21
ISSN
0092-8674 (ISSN-L)
OpenAlex
W3097717913
Cited by
238
References
71
Citations by year
2026: 35 · 2025: 48 · 2024: 40 · 2023: 39 · 2022: 38 · 2021: 28 · 2020: 1 · 2015: 1 · 2013: 1 · 2012: 2
FWCI
19.05
Type
journal article
Language
en
Open access
Locations
  • Cell (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Core Research for Evolutional Science and Technology
  • Japan Agency for Medical Research and Development (19cm010654, 20cm0106576, 20ck0106471, JP20cm0106206)
  • Japan Society for the Promotion of Science (JP17H06176)
Topics
  • Health Sciences › Medicine › Epidemiology › Neuroendocrine Tumor Research Advances
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
  • Health Sciences › Medicine › Neurology › Neuroblastoma Research and Treatments
Keywords
gastroenteropancreatic neuroendocrine tumors, neuroendocrine carcinoma, organoids, biobanks, genotype-phenotype mapping, TP53, RB1, loss of heterozygosity, transcription factors, molecular subtypes, colonic epithelium
MeSH terms
Whole Genome Sequencing, Animals, Chromosomes, Human, Genotype, Humans, Intestinal Neoplasms, Male, Models, Genetic, Mutation, Organoids, Pancreatic Neoplasms, Phenotype, Stomach Neoplasms, Biological Specimen Banks, Neuroendocrine Tumors, Intercellular Signaling Peptides and Proteins, Mice, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review